+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anxiety Drugs Market Research Reports

From
From
Generalized Anxiety Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Generalized Anxiety Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Obsessive Compulsive Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Obsessive Compulsive Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
mGlu 2/3/5 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

mGlu 2/3/5 Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
mGlu 2/3 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

mGlu 2/3 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Panic disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Panic disorder - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Acute Social Anxiety Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Social Anxiety Disorder - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
General Anxiety Disorder (GAD) - Pipeline Insight, 2024 - Product Thumbnail Image

General Anxiety Disorder (GAD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Obsessive-Compulsive Disorder Drugs Market 2024-2028 - Product Thumbnail Image

Obsessive-Compulsive Disorder Drugs Market 2024-2028

  • Report
  • December 2023
  • 159 Pages
  • Global
From
Nadolol (CAS 42200-33-9) Global Market Research Report 2024 - Product Thumbnail Image

Nadolol (CAS 42200-33-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Nefazodone (CAS 83366-66-9) Global Market Research Report 2024 - Product Thumbnail Image

Nefazodone (CAS 83366-66-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Meprobamate (CAS 57-53-4) Global Market Research Report 2024 - Product Thumbnail Image

Meprobamate (CAS 57-53-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Loading Indicator

The Anxiety Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat anxiety disorders. Anxiety drugs are typically prescribed to treat a variety of conditions, including generalized anxiety disorder, panic disorder, social anxiety disorder, and post-traumatic stress disorder. Commonly prescribed anxiety drugs include benzodiazepines, selective serotonin reuptake inhibitors (SSRIs), and tricyclic antidepressants. Anxiety drugs are typically prescribed by a doctor or mental health professional. The drugs are usually taken orally, although some may be administered intravenously or intramuscularly. The dosage and duration of treatment vary depending on the individual's condition and response to the drug. Some of the major companies in the Anxiety Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca, and Johnson & Johnson. These companies produce a variety of anxiety drugs, including benzodiazepines, SSRIs, and tricyclic antidepressants. Show Less Read more